| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adhesion molecules, mycophenolate mofetil and systemic lupus erythematosus
|
Lewis, MJ
|
|
2005
|
|
1S |
p. s17-s26
|
artikel
|
| 2 |
Amaurosis fugax, Crohn's Disease and the Anticardiolipin Antibody
|
Greenfield, S.M.
|
|
1993
|
|
1S |
p. 271-273
|
artikel
|
| 3 |
Antimalarial drugs in pregnancy — the North American experience
|
Parke, AL
|
|
1996
|
|
1S |
p. S67-S69
|
artikel
|
| 4 |
Anti-malarial drugs: possible mechanisms of action in autoimmune disease and prospects for drug development
|
Fox, R.
|
|
1996
|
|
1S |
p. S4-S10
|
artikel
|
| 5 |
Antimalarial Drugs, Pregnancy and Lactation
|
Parke, Ann L.
|
|
1993
|
|
1S |
p. S21-S23
|
artikel
|
| 6 |
Antimalarials in Sjogren's syndrome-the Greek experience
|
Manoussakis, MN
|
|
1996
|
|
1S |
p. S28-S30
|
artikel
|
| 7 |
Detection of Anti-Phospholipid and Anti-DNA Antibodies and their Idiotypes in Newborns of Mothers with Anti-Phospholipid Syndrome and SLE
|
Zurgil, N.
|
|
1993
|
|
1S |
p. 233-237
|
artikel
|
| 8 |
Effect of Sex on the Induction of Anti-DNA Antibodies in Normal Mice Immunized with Bacterial DNA
|
Palmer, Scott M.
|
|
1993
|
|
1S |
p. 251-255
|
artikel
|
| 9 |
Foreword
|
Hughes, G.
|
|
1996
|
|
1S |
p. S1-S1
|
artikel
|
| 10 |
Hepatic Infarction in a Pregnant Patient with the 'Primary' Antiphospholipid Syndrome
|
Millan-Mon, A.
|
|
1993
|
|
1S |
p. 275-279
|
artikel
|
| 11 |
Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis
|
Petri, M.
|
|
1996
|
|
1S |
p. S16-S22
|
artikel
|
| 12 |
Instructions for Contributors
|
|
|
1993
|
|
1S |
p. 224-225
|
artikel
|
| 13 |
Interstitial Inflammatory and Chronic Tubulointerstitial Lesions in Lupus Nephritis: Comparison with Those in IgA Nephropathy
|
Yamamoto, Tatsuo
|
|
1993
|
|
1S |
p. 261-268
|
artikel
|
| 14 |
Introduction
|
Hughes, Graham RV
|
|
2005
|
|
1S |
p. s1-s1
|
artikel
|
| 15 |
Introduction
|
Rynes, Richard I.
|
|
1993
|
|
1S |
p. S1-S1
|
artikel
|
| 16 |
Lupus nephritis: induction therapy
|
Chan, TM
|
|
2005
|
|
1S |
p. s27-s32
|
artikel
|
| 17 |
Lymphocyte Subsets in a Large Cohort of Patients with Systemic Lupus Erythematosus
|
Erkeller- Yüksel, Feza
|
|
1993
|
|
1S |
p. 227-231
|
artikel
|
| 18 |
Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide
|
Contreras, G.
|
|
2005
|
|
1S |
p. s33-s38
|
artikel
|
| 19 |
Maternal Autoantibodies and Congenital Heart Block: No Evidence for the Existence of a Unique Heart Block-associated Anti-Ro/SS-A Autoantibody Profile
|
Meilof, J.F.
|
|
1993
|
|
1S |
p. 239-246
|
artikel
|
| 20 |
Mechanism of Action of Antimalarial Drugs: Inhibition of Antigen Processing and Presentation
|
Fox, Robert I.
|
|
1993
|
|
1S |
p. S9-S12
|
artikel
|
| 21 |
Mechanisms of action of mycophenolate mofetil
|
Allison, AC
|
|
2005
|
|
1S |
p. s2-s8
|
artikel
|
| 22 |
MMF and eye disease
|
Zierhut, M.
|
|
2005
|
|
1S |
p. s50-s54
|
artikel
|
| 23 |
Mycophenolate mofetil and myasthenia gravis
|
Ciafaloni, E.
|
|
2005
|
|
1S |
p. s46-s49
|
artikel
|
| 24 |
Mycophenolate mofetil and neurological diseases
|
Vermersch, P.
|
|
2005
|
|
1S |
p. s42-s45
|
artikel
|
| 25 |
Mycophenolate mofetil and skin diseases
|
Hartmann, M.
|
|
2005
|
|
1S |
p. s58-s63
|
artikel
|
| 26 |
Mycophenolate mofetil and systemic lupus erythematosus: an overview
|
Pisoni, CN
|
|
2005
|
|
1S |
p. s9-s11
|
artikel
|
| 27 |
Mycophenolate mofetil in animal models of autoimmune disease
|
Zandman-Goddard, G.
|
|
2005
|
|
1S |
p. s12-s16
|
artikel
|
| 28 |
Mycophenolate mofetil in nonlupus glomerulonephropathy
|
Karim, MY
|
|
2005
|
|
1S |
p. s39-s41
|
artikel
|
| 29 |
Mycophenolate mofetil in patients with hepatitis C virus infection
|
Ramos-Casals, M.
|
|
2005
|
|
1S |
p. s64-s72
|
artikel
|
| 30 |
Mycophenolate mofetil in systemic vasculitis
|
D'Cruz, DP
|
|
2005
|
|
1S |
p. s55-s57
|
artikel
|
| 31 |
Ophthalmologic considerations in using antimalarials in the United States
|
Rynes, Richard I
|
|
1996
|
|
1S |
p. S73-S74
|
artikel
|
| 32 |
Ophthalmologic Safety Profile of Antimalarial Drugs
|
Rynes, Richard I.
|
|
1993
|
|
1S |
p. S17-S19
|
artikel
|
| 33 |
Pericardial Complication of Neuropsychiatric Systemic Lupus Erythematosus
|
Sarkar, David
|
|
1993
|
|
1S |
p. 269-270
|
artikel
|
| 34 |
Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases
|
Furst, Daniel E
|
|
1996
|
|
1S |
p. S11-S15
|
artikel
|
| 35 |
Reflex Seizures as Initial Manifestations of Systemic Lupus Erythematosus in Childhood
|
Brinciotti, Mario
|
|
1993
|
|
1S |
p. 281-283
|
artikel
|
| 36 |
Relationship of IL-2, IL-2R (CD25+), Soluble IL-2R and IL-4 with Disease Activity in SLE Patients
|
Cuadrado, Maria J.
|
|
1993
|
|
1S |
p. 257-260
|
artikel
|
| 37 |
Retinopathy and antimalarial drugs — the British experience
|
Spalton, DJ
|
|
1996
|
|
1S |
p. S70-S72
|
artikel
|
| 38 |
Role of antimalarials in rheumatoid arthritis — the British experience
|
Davis, MJ
|
|
1996
|
|
1S |
p. S37-S40
|
artikel
|
| 39 |
Standardized Ultraviolet-A Exposure Provokes Skin Reaction in Systemic Lupus Erythematosus
|
Nived, Ola
|
|
1993
|
|
1S |
p. 247-250
|
artikel
|
| 40 |
The efficacy of antimalarials in systemic lupus erythematosus
|
Nayak, V.
|
|
1996
|
|
1S |
p. S23-S27
|
artikel
|
| 41 |
The Efficacy of Antimalarials in Systemic Lupus Erythematosus
|
Esdaile, John M.
|
|
1993
|
|
1S |
p. S3-S8
|
artikel
|
| 42 |
The history of antimalarials
|
Wallace, DJ
|
|
1996
|
|
1S |
p. S2-S3
|
artikel
|
| 43 |
The Relevance of Antimalarial Therapy with Regard to Thrombosis, Hypercholesterolemia Cytokines in SLE
|
Wallace, Daniel J.
|
|
1993
|
|
1S |
p. S13-S15
|
artikel
|
| 44 |
The role of anti-malarials in rheumatoid arthritis — the American experience
|
Khraishi, MM
|
|
1996
|
|
1S |
p. S41-S44
|
artikel
|
| 45 |
The use of antimalarials in combination with other disease modifying agents in RA — the British experience
|
Duncan, MR
|
|
1996
|
|
1S |
p. S50-S58
|
artikel
|
| 46 |
The use of antimalarials in combination with other disease modifying agents in rheumatoid arthritis—the French Experience
|
Kahan, A.
|
|
1996
|
|
1S |
p. S45-S49
|
artikel
|
| 47 |
The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review
|
Wallace, DJ
|
|
1996
|
|
1S |
p. S59-S64
|
artikel
|
| 48 |
The use of hydroxychloroquine in lupus pregnancy : the British experience
|
Khamashta, MA
|
|
1996
|
|
1S |
p. S65-S66
|
artikel
|
| 49 |
Treatment of primary Sjögren's syndrome with hydroxychloroquine : a retrospective, open-label study
|
Fox, RI
|
|
1996
|
|
1S |
p. S31-S36
|
artikel
|
Tijdschrift beschrijving